BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Arrowhead Pharmaceuticals Reports Fiscal 2024 First Quarter Results

  Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2024 first quarter ended December 31, 2023.

  February 6, 2024

   · 

  8 min read
• Genetown

  Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 06, 2024

  Viridian Therapeutics, Inc. announced that a majority of the independent directors serving on the Compensation Committee of the company’s Board of Directors approved the grant of non-qualified stock options to an employee to purchase up to 30,000 shares of the company’s common stock on February 1, 2024.

  February 6, 2024

   · 

  2 min read
• Job Trends

  Gilead Sciences Announces 2.7 Percent Increase in First Quarter 2024 Dividend

  Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company’s Board of Directors has declared an increase of 2.7% in the company’s quarterly cash dividend, beginning in the first quarter of 2024.

  February 6, 2024

   · 

  1 min read
• Business

  Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results

  Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2023.

  February 6, 2024

   · 

  34 min read
• Business

  BioSyent Declares First Quarter 2024 Dividend

  BioSyent Inc. is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on March 15, 2024, to shareholders of record at the close of business on February 29, 2024.

  February 6, 2024

   · 

  1 min read
• BioMidwest

  Neogen® Announces James Walter as Vice President, Global Operations

  Neogen® Corporation announced that the Company has appointed James Walter to the position of Vice President, Global Operations.

  February 6, 2024

   · 

  2 min read
• Business

  Cardinal Health Board of Directors Approves Quarterly Dividend - February 06, 2024

  Cardinal Health announced that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company’s capital surplus.

  February 6, 2024

   · 

  1 min read
• BioCapital

  NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

  NexImmune, Inc. announced the closing of its previously announced registered direct offering of 304,731 shares of its common stock at a purchase price of $12.05 per share in a registered direct offering priced at-the-market under Nasdaq rules.

  February 6, 2024

   · 

  5 min read
• Business

  atai Life Sciences Appoints Anne Johnson as Chief Financial Officer

  atai Life Sciences announced that Anne Johnson, the Company’s interim Chief Financial Officer since October 2023 and Chief Accounting Officer since August 2022, has been named Chief Financial Officer.

  February 6, 2024

   · 

  3 min read
• Biotech Bay

  89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

  89bio, Inc. announced that the Company’s Management will present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024 at 1:20 PM EST and participate in one-on-one investor meetings.

  February 6, 2024

   · 

  1 min read